) Item 1.01 Entry into a Material Definitive Agreement. Private Placement Securities Purchase Agreement On October 27, 2025, SRx Health Solutions,...
Vous n'êtes pas connecté
Maroc - WN.COM - Health - 31/Oct 21:58
) Item 1.01 Entry into a Material Definitive Agreement. Private Placement Securities Purchase Agreement On October 27, 2025, SRx Health Solutions, Inc., a Delaware corporation (the "Company"), entered into a Securities Purchase Agreement (the "Securities Purchase Agreement") with certain accredited investors named therein. Pursuant to the Securities Purchase Agreement, up to 38,070 shares of the Company's Series A convertible preferred stock, par value $0.001 per share (the "Series A Preferred Stock") and accompanying warrants ("Warrants") to purchase shares of the Company's common stock, par value $0.001 per share (the "Common Stock") may be...
) Item 1.01 Entry into a Material Definitive Agreement. Private Placement Securities Purchase Agreement On October 27, 2025, SRx Health Solutions,...
) Item 1.01 Entry into a Material Agreement Securities Repurchase Agreement On October 29, 2025, LM Funding America, Inc. (the "Company")...
) Item 1.01 Entry into a Material Agreement Securities Repurchase Agreement On October 29, 2025, LM Funding America, Inc. (the "Company")...
) Item 1.01 Entry into a Material Definitive Agreement. On October 20, 2025, BrightSpring Health Services, Inc. (the "Company") entered into...
) Item 8.01 Other Events. Exercise of Warrants On October 24, 2025, certain holders of warrants exercised warrants at an exercise price of $0.70 per...
) Item 8.01 Other Events. Exercise of Warrants On October 24, 2025, certain holders of warrants exercised warrants at an exercise price of $0.70 per...
WALTHAM, Mass.--(BUSINESS WIRE)--Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biotechnology company focused on discovering, developing and...
) Item 1.01 Entry into a Material Definitive Agreement On October 21, 2025, VSee Health, Inc. (the "Company"), entered into an Amendment No....
) Table of Contents Filed Pursuant to Rule 424(b)(5) Registration No. 333-289887 PROSPECTUS LM FUNDING AMERICA, INC. Up to 52,668,995 Shares of Common...
) Table of Contents Filed Pursuant to Rule 424(b)(5) Registration No. 333-289887 PROSPECTUS LM FUNDING AMERICA, INC. Up to 52,668,995 Shares of Common...